Announcements Trials
Browse Landscape

Status

Completed 6Terminated 3Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Opioid-Induced Constipation 1

Interventions

Tirzepatide 5Educational Status 4naldemedine 3Methods 3Interviews as Topic 3Early Intervention, Educational 3semaglutide 2Tablets 2Standard of Care 2Specimen Handling 2Radiotherapy 2Paclitaxel 2Observation 2Mouthwashes 2Metformin 2Exercise 2Counseling 2Cisplatin 2Carboplatin 2trametinib 1tempol 1sotorasib 1selpercatinib 1polyethylene glycol 3350 1pembrolizumab 1osimertinib 1naloxegol 1mirabegron 1maltodextrin 1ma zi ren wan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × naloxegol × Other × Clear all
NCT03720613 2025-02-12

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

BioDelivery Sciences International

Recruiting
34,532 enrolled
Other

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡